Method of and system for selective cell destruction

Abstract

Method and apparatus for the ionization of living cells where an optical device (14) delivers an optical pulse having an optical field power which is modified locally by an optical field power modifying means (18) to effect ionization and destruction of living cells (16).

Description

RELATED APPLICATIONS[0001]This application is a Divisional of U.S. patent application Ser. No. 10 / 562,001, filed on May 1, 2006, which is a US National Phase Patent Application of PCT Application No. PCT / IL2004 / 000491 having International Filing Date of Jun. 9, 2004, which claims the benefit of Israel Patent Application No. 156626, filed on Jun. 24, 2003. The contents of the above Applications are all incorporated herein by reference.FIELD AND BACKGROUND OF THE INVENTION[0002]The present invention relates to a method and system for destruction of biological tissues and / or cells via selective ionization and, more particularly, to a method of ionizing biological tissues and / or cells using metallic nano-particles and electromagnetic irradiation.[0003]Cancer is a major cause of death in the modern world. Effective treatment of cancer is most readily accomplished following early detection of malignant tumors. Most techniques used to treat cancer (other than chemotherapy) are directed aga...

AI Technical Summary

Benefits of technology

This approach allows for more effective and localized destruction of cancer cells deep within tissues, reducing the need for invasive surgical techniques and minimizing side effects, while enhancing the treatment's depth penetration and efficiency.

Problems solved by technology

Cancer is a major cause of death in the modern world.

These small clusters of cells, which are more properly referred to as microscopic diffuse metastatic deposits, are not localizable and are virtually impossible to treat other than by systemic chemotherapy or radiotherapy.

Yet, because of the diverse nature of cancer cells, only a portion of the metastatic abnormal cells will likely be susceptible to chemotherapy or radiotherapy, leaving abnormal cells that are resistant to the therapy to multiply until the patient dies from the concomitant effects of the malignant cells.

Known PDT techniques suffer from a number of drawbacks and limitations.

One disadvantage of such PDT delivery system is that a typical fiber optic catheter transmits only about 30% to 50% of available light energy.

Additional energy losses occur in the diffuser which surrounds the light-emitting end of the catheter and diffuses the light emanating from the catheter.

Besides increasing the required size and cost of the light source, these energy losses also reduce the effectiveness of the treatment since the depth of radiation penetration into the tissue is reduced.

Another drawback of PDT techniques is that the photosensitizing drug remains in the bloodstream for six weeks or more, causing patients to be extremely light sensitive during that time period.